Influence of preservation solution on early graft failure in clinical lung transplantation

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 7, 2001, Pages 1204-1208

  Thabut, Gabriel ^b   Vinatier, Isabelle ^b   Brugière, Olivier ^b   Lesèche, Guy ^b   Loirat, Philippe ^b   Bisson, Alain ^b   Marty, Jean ^b   Fournier, Michel ^b   Mal, Hervé ^a  

^a BEAUJON HOSPITAL   (France)

^b NONE

Author keywords

Lung transplantation; Organ preservation solutions; Prognosis; Reperfusion injury

Indexed keywords

CAMBRIDGE SOLUTION; CELSIOR; EURO COLLINS SOLUTION; PRESERVATION SOLUTION; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; FRANCE; GRAFT FAILURE; HUMAN; LUNG TRANSPLANTATION; MALE; ORGAN DONOR; ORGAN PRESERVATION; PRIORITY JOURNAL; PROGNOSIS; REIMPLANTATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TECHNIQUE; TREATMENT OUTCOME;

EID: 0035482539     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.7.2012135     Document Type: Article

References (37)

1. Lung transplantation
2. Lung transplantation
3. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report - 1999
4. Acme pulmonary edema after lung transplantation: The pulmonary reimplantation response
5. Primary graft failure following lung transplantation
6. Pulmonary reimplantation response in single-lung transplantation
7. Early release of proinflammatory cytokines after lung transplantation
8. Pulmonary graft preservation: A worldwide survey of current clinical practice
9. Donor lung procurement: Assessment and operative technique
10. Protective effects of Celsior in lung transplantation
11. Beneficial effects of leukocyte-depleted blood and low-potassium dextran solutions on microvascular permeability in preserved porcine lung
12. A comparison of the new preservation solution Celsior to Euro-Collins and University of Wisconsin solutions in lung reperfusion injury
13. A comparison of intracellular solutions for donor heart preservation
14. Technique of successful lung transplantation in humans
15. A new technique for double lung transplantation. "Bilateral single lung" transplantation
16. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation
17. Ischemia-reperfusion injury in the isolated rat lung. Role of flow and endogenous leukocytes
18. Reimplantation response in isografted rat lungs. Analysis of causal factors
19. Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation
20. Pulmonary vascular permeability after lung transplantation. A positron emission tomographic study
21. Lung transplant edema: Chest radiography after lung transplantation - The first 10 days
22. Early lung allograft function in twin recipients from the same donor: Risk factor analysis
23. Pulmonary allograft ischemic time: An important predictor of survival after lung transplantation
24. Influence of graft ischemic time and donor age on survival after lung transplantation
25. Lung preservation: A review of current practice and future directions
26. Both blood and crystalloid-based extracellular solutions are superior to intracellular solutions for lung preservation
27. Impact of initial flush potassium concentration on the adequacy of lung preservation
28. The superiority of an extracellular fluid solution over Euro-Collins solution for pulmonary preservation
29. Acellular low-potassium dextran preserves pulmonary function after 48 hours of ischemia
30. Lung preservation with Euro-Collins, University of Wisconsin, Wallwork, and low-potassium-dextran solution
31. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation
32. A clinical trial of University of Wisconsin solution for pulmonary preservation
33. Lung procurement by low-potassium dextran and the effect on preservation injury
34. Ischemia/reperfusion injury after clinical lung transplantation
35. High potassium contents in organ preservation solutions cause strong pulmonary vaso-contraction
36. The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes
37. Effects of lung preservation solutions on PMN activation in vitro